← Leaderboards
Lana X Garmire
University Of Hawaii At Manoa
$8,953,254
Attributed
$8,953,254
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,953,254 · 6
By mechanism
R01$6,408,776 · 3
P20$1,336,140 · 1
K01$905,080 · 1
R03$303,258 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Hawaii At Manoa
Same institution · by research overlap
- Wade T Kyono$1,554,226
- Gertraud Maskarinec$12,414,805
- George S Hui$8,974,480
- Joseph Keawe'aimoku Kaholokula$16,281,171
- May Okihiro$212,491
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenomicsTranscriptome SequencingMethylomeComputing MethodologiesBioinformaticsTechnologyResearch PersonnelTissuesGenesUniversitiesBaseGenome-WideHeterogeneityCellsPlayBiologicalUser-FriendlyData IntegrationExome SequencingData SetExperimental StudyTranscriptomeBig Data
Grant awards (29)
Personalized cancer drug repurposing using single cell RNA-Seq data$303,258
R03 · FY2025 · OD · contact PI
Cancer precision medicine through spatially informative single cell image and transcriptomics data analysis$320,088
R01 · FY2024 · LM · contact PI
Cancer precision medicine through spatially informative single cell image and transcriptomics data analysis$320,446
R01 · FY2023 · LM · contact PI
DR. EPS: Drug Repurposing for Extended Patient Survival$341,835
R01 · FY2022 · LM · contact PI
DR. EPS: Drug Repurposing for Extended Patient Survival$1
R01 · FY2021 · LM · contact PI
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks$498,789
R01 · FY2020 · HD · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$368,125
R01 · FY2020 · LM · contact PI
DR. EPS: Drug Repurposing for Extended Patient Survival$355,836
R01 · FY2020 · LM · contact PI
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks$589,237
R01 · FY2019 · HD · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$368,125
R01 · FY2019 · LM · contact PI
DR. EPS: Drug Repurposing for Extended Patient Survival$339,300
R01 · FY2019 · LM · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$1,560
R01 · FY2019 · LM · contact PI
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks$619,249
R01 · FY2018 · HD · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$335,681
R01 · FY2018 · LM · contact PI
Project 3: Linking maternal obesity and offspring cancer risks through integrati$266,445
P20 · FY2018 · GM · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$156,157
K01 · FY2018 · ES · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$24,211
K01 · FY2018 · ES · contact PI
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks$614,177
R01 · FY2017 · HD · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$344,463
R01 · FY2017 · LM · contact PI
Project 3: Linking maternal obesity and offspring cancer risks through integrati$266,445
P20 · FY2017 · GM · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$180,368
K01 · FY2017 · ES · contact PI
An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks$636,642
R01 · FY2016 · HD · contact PI
An Integrative Bioinformatics Platform with Application in Single Cancer Cells$355,222
R01 · FY2016 · LM · contact PI
Project 3: Linking maternal obesity and offspring cancer risks through integrati$269,500
P20 · FY2016 · GM · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$180,368
K01 · FY2016 · ES · contact PI
Project 3: Linking maternal obesity and offspring cancer risks through integrati$267,750
P20 · FY2015 · GM · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$180,368
K01 · FY2015 · ES · contact PI
Project 3: Linking maternal obesity and offspring cancer risks through integrati$266,000
P20 · FY2014 · GM · contact PI
An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity$183,608
K01 · FY2014 · ES · contact PI